FindTrial
Sign In

A cohort study of patients with lupus erythematosus in Chinese population, from CCLCL

A cohort study of patients with lupus erythematosus in Chinese population, from Chinese Cutaneous Lupus Collaborating League (CCLCL)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072394
Enrollment
Unknown
Registered
2023-06-12
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus Erythematosus

Interventions

Systemic lupus erythematosus:N/A
Cutaneous lupus erythematosus:N/A

Sponsors

Hospital for skin diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Age 3 years and above, regardless of gender. ? Inclusion of patients with SLE: meeting either the 2019 EULAR/ACR SLE classification criteria or the 2012 SLICC SLE classification criteria will be included. ? Inclusion of patients with CLE: Referring to the Asian Dermatological Association (ADA) guidelines for the diagnosis, treatment, and long-term monitoring of cutaneous lupus erythematosus (2021), patients with any type of CLE, which were clinically diagnosed by considering the clinical and histopathological features of the patients. Including acute cutaneous lupus erythematosus (ACLE), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus erythematosus (CCLE). ACLE can be divided into two subtypes: limited and generalized; SCLE can be divided into two subtypes: annular erythematous and papulosquamous; CCLE can be divided into limited discoid lupus erythematosus (DLE), disseminated discoid lupus (DDLE), Verrucous lupus erythematosus (VLE), Tumid lupus erythematosus (TLE), lupus erythematosus profundus (LEP), Chilblain lupus erythematosus (CHLE), and Blaschko linear lupus erythematosus (BLLE). ? Sign the informed consent form, voluntarily participate in this project and be able to complete the interview assessment and take blood samples as required.

Exclusion criteria

Exclusion criteria: ? There are some factors that hinder the normal conduct of the questionnaire, such as mental abnormalities, visual or hearing impairments and so on. ? Refuse to participate in the process of informed consent.

Design outcomes

Primary

MeasureTime frame
Disease activity;Damage assessment;Laboratory examination;—

Countries

China

Contacts

Public ContactQianJin Lu

Hospital for skin diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China

qianlu5860@pumcderm.cams.cn+86 137 8709 7676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026